Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1983361

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1983361

Cyromazine Market, By Application (Crop Protection, Veterinary Medicines ), By Geography (North America, Latin America, Asia Pacific, Europe, and Middle East & Africa)

PUBLISHED:
PAGES: 132 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Cyromazine Market is estimated to be valued at USD 1.9 Bn in 2026 and is expected to reach USD 2.81 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 1.9 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 5.80% 2033 Value Projection: USD 2.81 Bn

Cyromazine is an insect growth regulator (IGR) or ectoparasiticide that disrupts the development of insects and is effective against leaf miners and fly larvae. Increasing population and rising disposable income of the population is resulting in huge demand for food items and agriculture products, which in turn increases the demand for IGRs.

Market Dynamics

Among application, crop protection segment is gaining traction in market, owing to increasing need for pest control in agriculture. For instance, according to Coherent Market Insights' analysis, the global pest control services market was valued around USD 16.18 Million in 2021. Cyromazine insect growth regulator possesses various advantages such as low toxicity and lesser impact on human health, and long-term effect, which are expected to moderately impact growth of the global cyromazine market.

Asia Pacific held a significant market share in 2021 due to substantial demand for cyromazine from China, India, South Korea, and Japan. Rising demand for agrochemicals, owing to increasing population in turn increases demand for agricultural products, thereby aiding in growth of the cyromazine market.

Key features of the study

  • This report provides an in-depth analysis of global cyromazine market, and provides market size (USD Bn) and compound annual growth rate (CAGR %) for the forecast period (2026-2033), considering 2025 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cyromazine market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Syngenta AG, ADAMA Agricultural Solutions Ltd., Elanco Animal Health Inc., Jurox Pty Limited., Arysta LifeScience Corporation, Lasa Supergenerics Limited, Orion AgriScience Limited, Topsen Biotech Co. Ltd., Shandong Luxi Animal Medicine Share Co., Ltd., Bayer AG, and Toronto Research Chemicals Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision regarding future product launches, technology up gradation, market expansion, and marketing tactics
  • The global cyromazine market report caters to various stakeholders in this industry including investors, suppliers, Cyromazine manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Cyromazine market

Market Segmentation

  • Application Insights (Revenue, USD Bn, 2026 - 2033)
    • Crop Protection
    • Veterinary Medicines
  • Regional Insights (Revenue, USD Bn, 2026 - 2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • North Africa
    • Central Africa
    • South Africa
  • Key Players Insights
    • Syngenta AG
    • ADAMA Agricultural Solutions Ltd.
    • Elanco Animal Health Inc.,
    • Jurox Pty Limited.
    • Arysta LifeScience Corporation
    • Lasa Supergenerics Limited
    • Orion AgriScience Limited,
    • Topsen Biotech Co. Ltd.
    • Shandong Luxi Animal Medicine Share Co., Ltd.
    • Bayer AG
    • Toronto Research Chemicals Inc.
Product Code: CMI2426

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Cyromazine Market, By Application
    • Global Cyromazine Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Key Developments
  • Industry Trend

4. Global Cyromazine Market, By Application, 2020-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Crop Protection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Veterinary Medicines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

5. Global Cyromazine Market, By Region, 2020 - 2033, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

6. Competitive Landscape

  • Syngenta AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • ADAMA Agricultural Solutions Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Elanco Animal Health Inc.,
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Jurox Pty Limited.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Arysta LifeScience Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lasa Supergenerics Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Orion AgriScience Limited,
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Topsen Biotech Co. Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Shandong Luxi Animal Medicine Share Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Toronto Research Chemicals Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

7. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

8. References and Research Methodology

  • References
  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!